Cover
Cover - shares | 3 Months Ended | |
Mar. 31, 2023 | May 12, 2023 | |
Cover [Abstract] | ||
Entity Registrant Name | BIONEXUS GENE LAB CORP. | |
Entity Central Index Key | 0001737523 | |
Document Type | 10-Q/A | |
Amendment Flag | true | |
Current Fiscal Year End Date | --12-31 | |
Entity Small Business | true | |
Entity Shell Company | false | |
Entity Emerging Growth Company | true | |
Entity Current Reporting Status | Yes | |
Document Period End Date | Mar. 31, 2023 | |
Entity Filer Category | Non-accelerated Filer | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2023 | |
Entity Ex Transition Period | false | |
Entity Common Stock Shares Outstanding | 173,718,152 | |
Entity File Number | 001-41750 | |
Entity Incorporation State Country Code | WY | |
Entity Tax Identification Number | 35-2604830 | |
Entity Address Address Line 1 | Unit 02, Level 10 Tower B, Avenue 3, The Vertical | |
Entity Address Address Line 2 | Business Suite II Bangsar South | |
Entity Address Address Line 3 | No. 8 Jalan Kerinchi | |
Entity Address City Or Town | Kuala Lumpur | |
Entity Address Postal Zip Code | 59200 | |
City Area Code | 307 | |
Local Phone Number | 241-6898 | |
Security 12b Title | Common stock, no par value | |
Trading Symbol | BGLC | |
Security Exchange Name | NASDAQ | |
Document Quarterly Report | true | |
Entity Interactive Data Current | Yes | |
Entity Address Country | MY | |
Document Transition Report | false | |
Amendment Description | This Amendment No. 1 on Form 10-Q/A (the “Amendment”) amends the Quarterly Report on Form 10-Q of BioNexus Gene Lab Corp. (the “Company”) for the fiscal quarter ended March 31, 2023 (the “Original Filings”). This Amendment is being filed solely to amend and restate in its entirety Part 1., Item 4 Controls and Procedures of the Original Filings. |